Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Clin Pharmacokinet. 2013 Aug;52(8):615–626. doi: 10.1007/s40262-013-0071-8

Fig. 2.

Fig. 2

Schematic diagram showing inhibition of various pathways by CETP inhibitors

ABCA1: adenosine triphosphate (ATP)-binding cassette transporter A1; ABCG1: ATP-binding cassette transporter G1; apo B: Apolipoprotein B; apoA-I: Apolipoprotein A-I; CE: cholesteryl esters; CETP: Cholesteryl ester transfer protein; FC: Free Cholesterol; HDL: High density lipoprotein; HL: Hepatic lipase; LCAT: Lecithin:cholesterol acyltransferase; LDL: Low density lipoprotein; LDL-R: low-density lipoprotein receptors; PL: Phospholipids; SR-B1: scavenger receptor class B member 1; TG: Triglyceride; VLDL: Very low density lipoprotein